The Pharma Fortress: India’s Healthcare Sovereignty vs. the US Section 301 Siege
📊Summary Glossary
• Section 301 Tariffs: US-imposed duties (10% to 12.5%) targeting 60 countries, including India, effective July 24, 2026.
• Pharmaceutical Trigger: Specialized tariffs on patented drugs and active pharmaceutical ingredients (APIs) effective July 31.
• Overcapacity Investigation: A US Trade Representative (USTR) probe into 16 economies to curb industrial "